Adrenocortical carcinoma with delayed cutaneous metastasis

Journal of Cutaneous Pathology

Volumn 35, Issue 7, 2008, Pages 677-680

  Satter, Elizabeth K ^a   Barnette, David J ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Scripps Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE;

ADRENAL CORTEX CARCINOMA; AGED; ANAMNESIS; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; SKIN BIOPSY; SKIN METASTASIS;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MIDDLE AGED; PROGNOSIS; RECURRENCE; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 44949138797     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00870.x     Document Type: Article

References (23)

1. Wooten MD, King DK. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993 72:3145.
2. Godil MA, Atlas MP, Parker RI, et al. Metastatic congenital adrenocortical carcinoma: a case report with tumor remission at 3 1/2 years. J Clin Endocrinol Metab 2000 85:3964.
3. Hogan TF, Gilchrist KW, Westing DW, Citrin DL. Adrenocortical carcinoma. Cancer 1980 45:2880.
4. Wajchenberg BL, Pereira MAA, Medonca BB, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000 88:711.
5. Stojadinovic A, Ghossein RA, Hoss A, et al. Adrenocortical carcinoma: clinical, morphological and molecular characterization. J Clin Oncol 2002 20:941.
6. Saracco S, Abramowsky C, Taylor S, Silverman RA, Berman BW. Spontaneously regressing adrenocortical carcinoma in a newborn. A case report with DNA ploidy anaylsis. Cancer 1988 62:507.
7. Assiè G, Antoni G, Tissier F, et al. Prognostic parameters of metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 2007 92:148.
8. Roudier C, Nguyen T, Grange F, et al. Cutaneous metastasis disclosing adrenal cortical carcinoma. Ann Dermatol Venereol 1994 121:42 (article in French).
9. Milchgrub S, Wiley EL. Adrenal carcinoma presenting as a lesion resembling cutaneous angiosarcoma. Cancer 1991 67:3087.
10. Lewinsky BS, Grigor KM, Symington T, Neville AM. The clinical and pathologic features of "non-hormonal" adrenocortical tumors. Cancer 1974 33:778.
11. Geller JL, Mertens RB, Weiss LW. Adrenocortical carcinoma. Many questions remain unanswered. Endocrinologist 2005 15:309.
12. Roman S. Adrenocortical carcinoma. Curr Opin Oncol 2006 18:36.
13. Beuschlein F, Looyenga BD, Reincke M, Giordana TJ, Hammer GD. Clinical impact of recent advances in the biology of adrenocortical cancer. Endocrinologist 2003 13:470.
14. Huvos AG, Hajdu SI, Brasfield RD, Foote FW. Adrenal cortical carcinoma. Clinicopathologic study of 34 cases. Cancer 1970 25:354.
15. Dominici A, Rizzo M, Travaglini F, Nesi G, Franchi A. Non-functioning adrenal cortical carcinoma presenting with metastasis to the tongue. J Oral Path Med 2003 32:185.
16. Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006 91:2027.
17. Loy TS, Phillips RW, Linder CL. A103 immunostaining in the diagnosis of adrenal cortical tumors. An immunohistochemical study of 316 cases. Arch Path Lab Med 2002 126:170.
18. Lam K-Y, Lo C-Y. Metastatic tumors of the adrenal glands: a 30-year experience at a teaching hospital. Clin Endocrinol 2002 56:95.
19. Ghorab Z, Jorda M, Ganjei P, Nadji M. Melan A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas. Appl Immunohistochem Mol Morphol 2003 11:330.
20. Busam KJ, Iversen K, Coplan KA, et al. Immunoreactivity for A103, an antibody to Melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Path 1998 22:57.
21. Lau SK, Weiss LW. Adrenocortical neoplasms. Pathology Case Reviews 2005 10:219.
22. Renshaw AA, Granter SR. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors. Mod Pathol 1998 11:1160.
23. Kebebew E, Reiff E, Duh Q-Y, Clark OH, McMillan A. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 2006 30:872.